Steve Vucic

Stories

Custom RNA drug improves rare ALS in first personalized case

External expert commenting on the results

A physician with rare inherited ALS received a drug built around his own gene mutation, the first therapy designed for this genetic form of the disease. A year after his first dose, his neuron-damage biomarker fell into the normal range and he kept practicing medicine.

Updated 3 hours ago